News from NYU Langone Health
New York University Langone receives $75 million gift for new medical tower in West Palm Beach. (Palm Beach Post (USA))
The Palm Beach Post (USA) (2/21) is sponsored by the Julia Koch Family Foundation. New York University Langone Health $75 million donation to “build a medical office tower in West Palm Beach.” NYU Langone officials said the blockbuster gift will allow the nonprofit health care provider to dramatically expand medical services to existing and new patients in Florida.
The New York Post (2/21) says the facility will “offer 76,000 square feet of clinical space, including on-demand specialty care in a wide range of areas including internal medicine, primary care, oncology and pain management.” Reporting. Robert I. Grossman, MD, Dean and CEO, New York University Langone Healthsaid, “Since our arrival in 2017, the demand for the exceptional care our team is already known for in New York has continued to grow in Florida.” He continued, “Thanks to the incredible generosity of the Julia Koch Family Foundation, we will be able to bring high standards to even more patients in a beautiful new location that will allow our team to work seamlessly between Florida and New York.” “We will be able to provide treatment for patients,” he added.
New York University Langone Health's Perlmutter Cancer Center Names New Neuro-Oncology Chair (Helio)
Helio (2/20) reports:Alexandra Miller, MD, Chief of Neuro-Oncology, Brain and Spine Tumor Center, Perlmutter Cancer Center” Mr. Miller is a neurologist and neuro-oncologist who specializes in treating primary brain tumors. She previously served as chief neurology resident and chief investigator in neuro-oncology at Memorial Sloan Kettering Cancer Center. ”
Isolated housing facilities and the proximity of transplant centers contribute to the disparity. (Helio)
Helio (2/19) discusses research on disparities in access to kidney transplants between black and white patients; Yiting Li, MPH, Senior Data Analyst, Surgical and Transplant Applied Research Centerstated that “living donor kidney transplantation (LDKT) remains the preferred method of renal replacement therapy.”
Episode 11: From Toxic Positivity to Practical Optimism with Dr. Sue Varma. (Nutritious life)
A nutritious life (2/20) Sudeepta Varma, MD, Clinical Assistant Professor of Psychiatry At New York University Langone, we discussed the balance between optimism and “toxic positivity.”
AAOS: Sports-related orthopedic injuries in older adults are projected to increase by 123% by 2040. (Drug Information Online)
Drug Information Online (2/20) New research suggests that “sports-related injuries in older adults are expected to increase by 123% between 2021 and 2040.” Dr. Jay Zeifman, Orthopedics Resident “There have traditionally been different protocols and treatments for this age group. We now need to consider the new, higher demands of many of these patients. It is important to reconsider the standard of care for active older adults.”
McKnight's Senior Living (2/20) also reports.
“Magic mushrooms” are making a comeback, especially in the Midwest. Here's why: (Cincinnati Enquirer)
Cincinnati Enquirer (2/20) A study funded by the National Institute on Drug Abuse shows “a dramatic increase in police seizures of psilocybin mushrooms across the United States, especially in the Midwest. “There are.” Joseph J. Palamar, MPH, PhD, Associate Professor, Department of Population Health “While we believe that more people are using shrooms, we lack data showing a growing trend in use,” said Dr. Langone Health, NYU. “This is because most do not specifically ask about shroom use.”
Women live longer by exercising less than men. (Daily health)
Everyday Health (2/15) A new study shows that the health and longevity benefits of exercise “may vary widely between men and women, with women getting more benefits in less time.” I am. Nika Goldberg, MD, Leon H. Charney Clinical Associate Professor, Department of Cardiology “While there are physiological differences between men and women when it comes to exercise, most of our exercise guidelines and protocols are based on men's exercise responses,” said Dr. Langone of New York University Langone Medical Center. Masu.
COVID-19 vaccines linked to small increases in heart, brain and blood disorders: study. (New York Post)
New York Post (2/20) New research suggests that COVID-19 vaccines are 'associated with rare heart, brain and blood disorders.' Mark K. Siegel, MD, Clinical Professor, School of Medicine, Department of General Internal Medicine at New York University Langone Medical Center, said, “Extensive research and review of data reveals a rare association between mRNA vaccines and myocarditis, particularly after the second dose, and an association with Oxford-AstraZeneca.'' has become clear.” Adenoviral vector vaccines and Guillain-Barre syndrome. ”
Upstract (2/20) and Daily Mirror (LKA) (2/20) also reported..
Tax records reveal the lucrative world of coronavirus misinformation. (Washington Post)
Washington Post (2/21) Discussing groups profiting from spreading misinformation about the COVID-19 pandemic; Dr. Arthur L. Caplan, Ph.D.William F. and Virginia Connolly Mitty Professor, Department of Population Health and Physician Ethics“These groups have given jet fuel to misinformation at a critical time in the pandemic. There is no doubt that the wealthier they get, the worse off the public's position is. Because you are spewing out dangerous nonsense that will kill you.”
Musk claims that Neuralink patients have no problems with the implant and can use their brains to move the mouse. (Ars Technica)
Ars Technica (2/20) Discussing Neuralink co-founder Elon Musk's announcement about the progress of the company's efforts to implant chips in human brains. Dr. Arthur L. Caplan, Ph.D.William F. and Virginia Connolly Mitty Professor, Department of Population Health and Physician EthicsJonathan Moreno, a professor of medical ethics at the University of Pennsylvania, wrote, “Science through press releases, although increasingly common, is not science.”
News from NYU Langone Hospital — Long Island
Meet Dr. Doug Marks, an oncology clinical trial physician. (American Journal of Managed Care)
American Managed Care Journal (2/20) Douglas K. Marks, MD, Assistant Professor, Department of Hematology-Oncology, New York University Langone Hospital, Long Island Medical School“I really enjoyed working with oncologists who treat all kinds of different cancers and making sure their patients get the clinical trials they need as well.'';
